These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12079913)

  • 21. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral neuropathy during infliximab therapy for rheumatoid arthritis.
    El Aidli S; Gaïes E; Cherif F; Zaiem A; Daghfous R; Lakhal M
    Presse Med; 2014 Sep; 43(9):1012-4. PubMed ID: 24742611
    [No Abstract]   [Full Text] [Related]  

  • 23. Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis.
    Chan AT; Cleeve V; Daymond TJ
    Postgrad Med J; 2002 Jan; 78(915):47-8. PubMed ID: 11796874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
    van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
    Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
    Asahina A; Ishii N; Tohma S
    J Dermatol; 2012 Feb; 39(2):199-201. PubMed ID: 21463364
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fibrosing alveolitis after treatement of rheumatoid arthritis by infliximab].
    Nouijai A; Mounach A; Ghozlani I; Achemlal L; Bezza A; El Maghraoui A
    Presse Med; 2009 Oct; 38(10):e17-20. PubMed ID: 19447578
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab.
    Fabre S; Gibert C; Lechiche C; Jorgensen C; Sany J
    J Rheumatol; 2005 Dec; 32(12):2432-3. PubMed ID: 16331777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor alpha for rheumatoid arthritis: a case report and discussion of literature.
    Silburn S; McIvor E; McEntegart A; Wilson H
    Ann Rheum Dis; 2008 Apr; 67(4):575-6. PubMed ID: 18349168
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
    Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
    J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    van Dartel SA; Fransen J; Kievit W; Flendrie M; den Broeder AA; Visser H; Hartkamp A; van de Laar MA; van Riel PL
    Ann Rheum Dis; 2013 Jun; 72(6):895-900. PubMed ID: 22887849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late onset of long-lasting fever as a sole complication of treatment with anti-TNFalpha.
    Tassiopoulos S; Benopoulou O; Mytilineou E; Andreopoulos A; Vaiopoulos G
    Clin Exp Rheumatol; 2005; 23(1):122-3. PubMed ID: 15789902
    [No Abstract]   [Full Text] [Related]  

  • 33. Discoid lupus erythematosus-like eruption induced by infliximab.
    Stratigos AJ; Antoniou C; Stamathioudaki S; Avgerinou G; Tsega A; Katsambas AD
    Clin Exp Dermatol; 2004 Mar; 29(2):150-3. PubMed ID: 14987271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate.
    Lutman C; Finocchiaro G; Abate E; Milo M; Morassi P; Sinagra G
    J Cardiovasc Med (Hagerstown); 2014 Dec; 15(12):880-2. PubMed ID: 25083725
    [No Abstract]   [Full Text] [Related]  

  • 35. Infliximab induced lupus in patients with rheumatoid arthritis.
    Elkayam O; Caspi D
    Clin Exp Rheumatol; 2004; 22(4):502-3. PubMed ID: 15301255
    [No Abstract]   [Full Text] [Related]  

  • 36. Polymyositis associated with infliximab treatment for rheumatoid arthritis.
    Musiał J; Undas A; Celińska-Lowenhoff M
    Rheumatology (Oxford); 2003 Dec; 42(12):1566-8. PubMed ID: 14645861
    [No Abstract]   [Full Text] [Related]  

  • 37. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
    Danko JR; Gilliland WR; Miller RS; Decker CF
    Scand J Infect Dis; 2009; 41(4):252-5. PubMed ID: 19266397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient.
    Josse S; Klemmer N; Moreno-Swirc S; Goëb V; Lequerré T; Vittecoq O
    Joint Bone Spine; 2009 Dec; 76(6):718-9. PubMed ID: 19464223
    [No Abstract]   [Full Text] [Related]  

  • 39. Haemophagocytic syndrome in a rheumatoid arthritis patient treated with infliximab.
    Aouba A; De Bandt M; Aslangul E; Atkhen N; Patri B
    Rheumatology (Oxford); 2003 Jun; 42(6):800-2. PubMed ID: 12771439
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody.
    Mori S; Imamura F; Kiyofuji C; Sugimoto M
    Mod Rheumatol; 2006; 16(4):251-5. PubMed ID: 16906378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.